Clinical implications of seropositive and seronegative autoantibody status in rheumatoid arthritis patients: A comparative multicentre observational study.
Nevin HammamPassant N El-HusseinySuzan S Al-AdleNermeen SamyNora Y ElsaidDina F El-EssawiEman F MohamedSamar M FawzySamah A El BakryMaha NassrSamah I NasefHanan M El-SaadanyShereen ElwanNada M GamalAbdelhfeez MoshrifOsman HammamRawhya R El ShereefFaten IsmailSamar TharwatDoaa Mosad MosaMervat I Abd ElazeemEnas A AbdelaleemTamer A Gheitanull nullPublished in: Rheumatology and immunology research (2024)
Dual antibody-positive status has higher disease activity and severity, and higher chance of development of metabolic syndrome; highlighting the implicated role of inflammation, atherogenesis and cardiovascular disease risk in RA.
Keyphrases
- disease activity
- rheumatoid arthritis patients
- rheumatoid arthritis
- systemic lupus erythematosus
- metabolic syndrome
- cardiovascular disease
- ankylosing spondylitis
- juvenile idiopathic arthritis
- oxidative stress
- clinical trial
- insulin resistance
- cardiovascular risk factors
- study protocol
- type diabetes
- randomized controlled trial
- interstitial lung disease
- adipose tissue